---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-120915"
form_type: "8-K"
ticker: "HUMA"
cik: "0001818382"
company_name: "Humacyte, Inc."
filed_at: "2025-12-15T23:59:59+00:00"
generated_at: "2026-05-16T13:14:55.760327+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Humacyte terminates Revenue Interest Purchase Agreement; pays $38M cash + 5.7M shares to purchasers

## Summary
- Terminated Revenue Interest Purchase Agreement and Option Agreement with TPC Investments LP and Hook SA LLC as of Dec 15, 2025.
- Consideration: $38 million cash (funded via new credit facility) plus 5,725,190 shares of common stock in a registered direct offering.
- Offering closes Dec 15, 2025; shares issued under effective shelf registration statement (File No. 333-290231).
- Company expects to fund $38M cash payment from proceeds of a new credit facility.
- Satisfaction of all obligations under terminated agreements.

## SEC filing metadata
- accession: 0001104659-25-120915
- form_type: 8-K
- ticker: HUMA
- cik: 0001818382
- company_name: Humacyte, Inc.
- filed_at: 2025-12-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818382/000110465925120915/0001104659-25-120915-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818382/000110465925120915/tm2533185d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-120915
- JSON: https://secwatch.observer/filing/0001104659-25-120915.json
- Plain text: https://secwatch.observer/filing/0001104659-25-120915.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.